Classification of the effectiveness of combination treatments

According to FDA regulations, a combination drug is not efficacious unless each component contributes to the claimed effects. For a univariate endpoint, this implies that the combination at specific doses must be superior to each of its components at the same doses. More demanding is the property of synergy, in which the effect of the combination must be superior to the effect expected based on those of its components. If it is equal to those effects, it is additive, and if it is inferior, it is antagonistic. We give regions in the combination dose plane where these concepts are well defined. If the effect of the combination is greater than the greatest effect achievable by any of its components it is therapeutically synergistic. A combination can be antagonistic, yet its components can still contribute to the claimed effects. If it is additive, synergistic or therapeutically synergistic, its components must contribute to the claimed effects. We relate these concepts and provide designs and sequential procedures for determining whether a combination is therapeutically synergistic, synergistic, additive, antagonistic and contributing or antagonistic and non-contributing.     

Electroluminescent zinc sulphide devices produced by sol-gel processing

Zinc sulphide thin film electroluminescent devices doped with Mn or Tb have been produced on p-type Si substrates using a process in which doped zinc oxide films are deposited by a sol-gel drain coating method from a solution of zinc acetate containing a manganese or terbium dopant. The films are then converted to ZnS by heating them in an atmosphere containing hydrogen sulphide which replaces the oxygyn with sulphur. The composition, crystalline structure and optical properties of films have shown that complete conversion from the oxide to the sulphide takes place. The luminescent characteristics of the devices so produced have been measured as a function of the doping concentrations, film thickness, insulator thickness and driving voltage and frequency. It has been found that yellow or green luminescence can be obtained using Mn or Tb doping respectively.     

粉末材料中微夹杂缺陷的超声波检验

介绍了用超声波方法检测微夹杂缺陷的一些试验结果，比较了不同频率、不同试验方法检测能力的差异，并通过解剖试验对检出缺陷的性质、尺寸作了比较。     

非线性隔振理论初探

本文以线必阻尼，立方刚度非线性系统为例，对非线性隔振理论进行了初步探讨，导出了系统的无量纲运动响应和传递率，并与线性隔振系统进行了比较，着重讨论了非线性对它们的影响，获得了一些有用的结论。     

一种获得透视图的新方法

依据物体透视图的人工作图法，本文提出了确定透视变换矩阵的新方法，这种方法基于一组新的参数，而每个参数与透视变换的结果有明显关系，因此便于使用，并给出了计算机作图示例。     

智能控制在回转窑配料系统中的应用

本文介绍智能控制在回转窑配料系统中的应用情况，并阐述该控制器设计、构成、软件系统特点及现场运行效果。     

氧化还原功能纤维的研究 Ⅷ．含正丙胺基吸附剂与Au~（3＋）的氧化还原反应机理

通过元素分析、红外光谱分析、光电子能谱分析以及扫描电子显微镜分析等手段，证实含正丙胺基吸附剂与Ａｕ３＋的氧化还原反应过程中，氮原子邻近的羟基碳或Ｃ－Ｈ键被氧化，而氮原子并未参与氧化还原反应；吸附态Ａｕ（３＋）最终部分被还原成单质金；在非水介质中吸附在吸附剂上的金聚集成颗粒状。     

Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis

To investigate the pathogenicity of Aspergillus fumigatus mutants lacking putative virulence factors, we have developed a new murine model of invasive pulmonary aspergillosis based on neutropenia, the major factor predisposing patients to this infection. Mice were treated with cyclophosphamide and inoculated by the intranasal route with 5 x 10(3) conidia, a significant reduction from inoculum levels used in previous models. Evidence for the production of the extracellular alkaline protease (Alp) in lung tissue was obtained by using a fungal transformant harboring an alp::lacZ reporter gene fusion. The pathogenicities of single mutant strains lacking either Alp or the ribotoxin restrictocin and of a double mutant strain lacking both proteins were assessed in this infection model. There were no significant differences between the mutant and the wild-type strains in terms of mortality or histological-features. Inoculations with mixtures of conidia showed that the double mutant strain is slightly less virulent than the wild-type strain. We conclude that Alp and restrictocin are not important virulence determinants in pulmonary infection.     

A cdc2-like kinase associated with commitment to division in Paramecium tetraurelia

Cell division in higher eukaryotes is mainly controlled by p34cdc2 or related kinases and by other components of these kinase complexes. We present evidence that cdc2-like kinases also occur in Paramecium. Two polypeptides reacted with an antibody directed against the perfectly conserved PSTAIR region found in cdc2 kinases in other eukaryotes. Only the less abundant peptide bound to p13suc1 from Schizosaccharomyces pombe. Using centrifugal elutriation to select cells on the basis of size, we isolated highly synchronous Paramecium G1 cells. With this procedure, we demonstrated that the p13suc1-associated cdc2-like histone H1 kinase was activated before cell division at the point of commitment to division in Paramecium. Further, we show that Paramecium cdc2-like proteins occurred principally as monomers and that these monomers were active as histone H1 kinases in vitro.